Pharmafile Logo

Reducing Carbon Footprint with Virtual Meetings – Perks of Virtual Medical Education

Discover how replacing in-person meetings with virtual alternatives can significantly cut carbon emissions and support environmental initiatives. Our latest video highlights the crucial role of virtual meetings in reducing the ecological impact of conferences. Join us in fostering a greener future!

Explore the environmental benefits of virtual meetings in our ninth video from the “Perks of Virtual Medical Education” series. Learn how shifting from in-person to virtual meetings can significantly reduce carbon emissions and support sustainability efforts.

9. The Environmental Footprint is Much Smaller with Virtual vs. In-Person Meetings The shift towards virtual meetings is not only a matter of convenience or cost but also a significant environmental decision. National and international in-person meetings often involve extensive travel that contributes to large carbon footprints. By incorporating virtual meetings, organizations can drastically cut down emissions associated with air travel and ground transportation. As the environmental movement gains momentum, and the pharmaceutical industry begins to embrace more sustainable practices, the preference for virtual participation continues to grow. Participants appreciate the option to engage from anywhere without the environmental cost of travel, and it is likely that such expectations will only increase in the future.

For more insights into how virtual meetings contribute to sustainability in medical education and beyond, visit our blog: https://www.impetusdigital.com/2020/09/17/top-10-reasons-why-virtual-collaboration-and-medical-education-will-persist-in-the-new-normal/

Enhance your sustainable engagement strategies with Impetus Digital:

Stay connected for more sustainable practices in medical education:

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

Gene Editing and Precision Medicine: The Future of Healthcare?

Dr. Oscar Segurado, Chief Medical Officer at ASC Therapeutics, dives into advanced gene therapies, gene editing, and personalized medicine. We also explore the many different hats he wears as CMO, consultant,...

CRM Design and Optimization for Life Science Organizations

John Leombruno, CEO of OkRx, shares how his company is working to improve PSP strategy and operations in Canada. He also discusses the impact of COVID-19 on PSPs, digital transformation, clinical...

Enabling Patient-Focused Research Through Virtual Clinical Trials

Chad Walsh, CEO of Sciteline, dives into virtual trials, including their benefits, barriers, and impact on patient-centricity. Among other things, we will discuss data privacy concerns, the role of digital...

Innovative Approaches to Managing Mental Health Conditions

Owen Muir, MD, CIO at Brooklyn Minds, explores the secondary effects of COVID-19 on mental health conditions, along with techniques such as deep Transcranial Magnetic Stimulation (dTMS), Mentalization-Based Treatment (MBT), and...

Looking back at the year when everything changed

COVID-19 has impacted every aspect of our lives, from the way we shop for groceries to the way we conduct work and interact with healthcare providers and our families.

PRESS RELEASE: IMPETUS DIGITAL LAUNCHES INSITE EVENTâ„¢

Impetus Digital launches InSite Event™ -  the most comprehensive virtual event platform for life science companies, delivered with white glove service

Risk Management, Ethics, and Compliance Considerations in the New Normal

Myriam Prescott, Head of Ethics, Risks and Compliance - Oncology, Novartis Canada, dissects the importance of effective patient engagement and strong compliance & monitoring programs. We also dive into the...

A Deep-Dive into the COVID-19 Pandemic and its Secondary Effects

Dr. Farah Fourcand, Author of Pandemic Manifesto, shares her experience working on the frontlines of the COVID-19 pandemic. She also dives into the psychological impact of COVID-19, lessons learned from the...

Women in Leadership: Barriers & Opportunities in the Life Science Industry

Allison Gaw, Executive Director, Corporate and Business Development at Chinook Therapeutics, discusses women in STEM, effective leadership, cross-border collaboration during COVID-19, the future of healthcare, and much more.

Highlighting Patient Voices, Workforce Well-Being & Health Literacy During & After the Pandemic

We explore the importance of health literacy, patient voices, and workforce wellbeing during COVID-19 with Deborah Collyar (Patient Advocates in Research), Cathryn Gunther (Population Health Alliance) & Catina O'Leary (Health...